• 1
    Lochs H, Dejong C, Hammarqvist F, et al. ESPEN Guidelines on Enteral Nutrition: Gastroenterology. Clin Nutr. 2006; 25: 260274.
  • 2
    Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000; 31: 815.
  • 3
    Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database System Rev. 2007; 1: CD000542.
  • 4
    Wiskin AE, Wootton SA, Beattie RM. Nutrition issues in pediatric Crohn's disease. Nutr Clin Pract. 2007; 22: 214222.
  • 5
    Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 1999; 14: 281289.
  • 6
    Rodrigues AF, Johnson T, Davies P, et al. Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease? Arch Dis Child. 2007; 92: 767770.
  • 7
    Johnson T, MacDonald S, Hill SM, et al. Treatment of active Crohn's disease using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006; 55: 356361.
  • 8
    El-Matary W. Enteral nutrition as a primary therapy of Crohn's disease: the pediatric perspective. Nutr Clin Pract. 2009; 24: 9197.
  • 9
    Middleton SJ, Rucker JT, Kirby GA, et al. Long chain triglycerides reduce efficacy of enteral feed. Clin. Nutr. 1995; 14: 229236.
  • 10
    Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991; 12: 439447.
  • 11
    Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007; 44: 653674.
  • 12
    Afzal NA, Davies S, Paintin M, et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci. 2005; 50: 14711475.
  • 13
    Department of Health. Report on Health and Social Subjects No. 4. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: HMSO; 1991.
  • 14
    Sutherland AD, Gearry BR, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Col Rectum. 2008; 51: 12831289.
  • 15
    Folch JL, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957; 226: 497509.
  • 16
    Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995; 108: 10561067.
  • 17
    Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol. 2000; 95: 735739.
    Direct Link:
  • 18
    Ludvigsson JF, Krantz M, Bodin L, et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr. 2004; 93: 327335.
  • 19
    Gavin J, Anderson CE, Bremner AR, et al. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy. J Hum Nut Dietet. 2005; 18: 337342.
  • 20
    Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut. 1993; 34: 11982102.
  • 21
    Gonzalez-Huix F, de Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled study. Gut. 1993; 34: 778782.
  • 22
    Knight C, El-Matary W, Spray C, et al. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr. 2005; 24: 775779.
  • 23
    Murphy MS, Randell T. Evaluation of elemental diet therapy as a long term strategy for managing Crohn's disease (abstract). J Pediatr Gastroenterol Nutr. 2001; 32: 366.
  • 24
    Turner D, Zlotkin SH, Shah PS, et al. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database System Rev. 2007; 2: CD006320.
  • 25
    Yaqoob P, Calder PC. Fatty acids and immune function: new insights into mechanisms. Br J Nutr. 2007; 98: S4145.
  • 26
    Carnielli VP, Rossi K, Badon T, et al. Medium-chain triacylglycerols in formulas for preterm infants: effect on plasma lipids, circulating concentrations of medium-chain fatty acids, and essential fatty acids. Am J Clin Nutr. 1996; 64: 152158.
  • 27
    Burdge GC, Calder PC. Dietary α-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev. 2006; 19: 2652.
  • 28
    Von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of faecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007; 102: 803813.
    Direct Link:
  • 29
    Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2000; 2: 353.